CMMB
Chemomab Therapeutics
CMMB
CMMB
15 hedge funds and large institutions have $35.9M invested in Chemomab Therapeutics in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2M | |
| 2 | +$608K | |
| 3 | +$338K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$152K |
| 5 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
+$133K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$837K | |
| 3 | -$251K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$125K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$58.4K |